AlgaEurope 2026 · Malta | Track 06 of 11
← All Tracks
AlgaEU
AlgaEurope 2026
4BlueTech
← Back to all tracks Track #06
AlgaEurope 2026 › Track #06
SESSION TRACK · #06 OF 11 · HUMAN NUTRITION

Algae in Food
Applications

From Spirulina tablets in the 1970s to precision-fermented algal proteins now entering supermarket shelves, the trajectory of microalgae in human food is defined by EU Novel Food regulation, consumer protein shifts, and advances in strain-specific flavour deodorisation.

Human Nutrition Dec 8–11 · Hilton Malta Novel Food · EU Regulation
€2.5 B
Global spirulina food market 2024 (Grand View Research)
65% DW
Protein content in Arthrospira — highest of any food
5 approved
Microalgae under EU Novel Food Regulation by 2024
+680 kJ/100g
Energy density of Nannochloropsis whole-cell powder
18%
EU consumers "willing to eat algae regularly" (EFSA survey 2022)
Regulatory Status
EU Novel Food Approval Status by Species — Regulation (EU) 2015/2283

The EU Novel Food Regulation requires pre-market safety assessment by EFSA before any microalgae not traditionally consumed in the EU as food can enter the market. Approval durations typically run 2–5 years. Key distinction: Arthrospira (Spirulina) and Chlorella are classified as "traditional" in some EU member states, bypassing the Novel Food route.

Species EU Novel Food status Authorised application Year
Arthrospira platensisTraditional foodGeneral food ingredient, dietary supplement—
Chlorella vulgarisTraditional foodGeneral food ingredient, dietary supplement—
Haematococcus pluvialisNF ApprovedDietary supplement (astaxanthin ≤ 8 mg/day)2022
Schizochytrium sp.NF ApprovedDHA-rich oil in food products (infant formula, bakery)2003
Nannochloropsis gaditanaNF ApprovedProtein ingredient in food supplements ≤ 3g/day2024
Odontella auritaUnder reviewApplication for EPA-rich whole-cell food ingredient2023 →
Tetraselmis chuiUnder reviewApplication for dried biomass in food supplements2022 →

Source: EFSA Novel Food Catalogue v2024, Regulation (EU) 2015/2283 on Novel Foods.

Protein Comparison
Protein Content (% DW) — Algal vs Conventional Sources
Spirulina (dried)
65% DW
Chlorella (whole cell)
58% DW
Nannochloropsis protein isolate
52% DW
Soy protein isolate
90% DW
Pea protein isolate
85% DW
Meat (chicken breast, dry)
72% DW
Eggs (whole dried)
48% DW

Note: soy and pea isolates represent processed protein concentrates. Algae values are whole-biomass. When processed to protein isolate, Spirulina approaches 85%+ DW. Source: Becker (2007) Advances in Biochemical Engineering; Grönberg & Sterte (2021) Food Chemistry.

Landmark Achievements
Commercial and Regulatory Milestones in Algal Food
2003
DSM Martek — First EU Novel Food approval for algal DHA oil in infant formula. Schizochytrium-derived DHASCO (DHA single-cell oil) became the first commercial algal ingredient approved for routine addition to infant formula in the EU and US. By 2010, it was present in 90% of EU infant formulas. Equivalent of protecting DHA supply for infants independent of fish stocks — a permanent regulatory shift in food-grade algal ingredients.
2013
Solazyme (now TerVia) — Algal oil in food at 300+ t/yr. Solazyme's AlgaVia lipid powder (whole-cell heterotrophic Chlorella) entered food service as fat replacement. Successfully deployed in ice cream, salad dressings, and cooking oils at commercial scale by 2013. Demonstrated that algal triglyceride profiles could match palm oil functionally — first head-to-head commercial displacement of a conventional fat source.
2022
EFSA Opinion on Haematococcus pluvialis as Novel Food — Astaxanthin in Supplements Authorised. After a 3-year safety assessment, EFSA published its positive opinion (EFSA Journal 2020;18(4):6049) enabling H. pluvialis extract as a food supplement at ≤8 mg astaxanthin/day. The Commission authorised it in 2022 under Implementing Regulation (EU) 2022/2278. Opened the European supplement market for natural astaxanthin, estimated at €120M/yr by 2025.
Innovation Pathways 2026–2030
Barriers to Consumer Uptake and Research-Level Solutions
Flavour Deodorisation

The primary barrier to algal food uptake is off-flavour: volatile compounds (DMS, hexanal, decadienal) cause "seaweed" or "fishy" notes. Research pathways: (1) fermentative deodorisation with Lactobacillus co-culture — 60–70% DMS reduction; (2) CO₂ supercritical extraction of lipophilic volatiles — removes up to 85% of fishy notes while retaining protein matrix; (3) strain selection programs at Roquette (France) using sensory GC-MS coupling to breed low-volatile Chlorella lines.

Whole-Food Texture Engineering

Unlike soy and pea proteins that have been reformulated for 50+ years, algal proteins lack established texturisation data. Current innovation: (1) extrusion texturisation of Spirulina at 20% inclusion into meat-analogue fibres (Wageningen 2023, Food Hydrocolloids 136:108314); (2) algal protein gelation at pH 7 for tofu-analogues — functional at Spirulina >12% DW; (3) encapsulation in resistant starch matrices for baked goods (Kern et al., 2022).

EU Consumer Acceptance — EFSA Survey Data (2022, n=6,542, 10 EU countries)

18%
willing to eat algae regularly
41%
would try algae if nutritionally framed
63%
unaware algae are already in EU infant formula

Principal barriers cited: unfamiliar flavour (68%), perceived safety concerns (44%), no clear labelling (38%). Communication strategy: normalise algal ingredients as "already in baby formula for 20 years" — significantly increases willingness-to-try in structured trials.